原发性高血压患者内皮祖细胞功能变化及与FMD的相关性
Change of the Functional Activity of Endothelial Progenitor Cells and Their Correlation with FMD in Primary Hypertension Patients
摘要: 目的：探究原发性高血压患者内皮祖细胞(endothelial progenitor cells, EPCs)功能的变化及与内皮依赖血管舒张功能(FMD)的相关性。方法：实验组为15例原发性高血压3级患者和对照组为同期健康体检者20人。取研究对象的外周血20 ml，CCK8法和Transwell小室检测EPCs功能(增殖、迁移)。结果：与对照组比较，高血压患者的EPCs的迁移、增殖功能明显较低(p < 0.05)；原发性高血压患者FMD明显低于正常对照组(p < 0.05)，同时我们发现循环内皮祖细胞迁移和增殖分别与FMD强正相关(分别为r = 0.56，0.41，p < 0.05)。结论：原发性高血压EPC的功能下降，可能与FMD损伤有关。
Abstract: Objective: To investigate change of the function of endothelial progenitor cells (EPCs) and their correlation with flow-mediated dilation (FMD) in patients with primary hypertension. Methods: 15 patients with grade 3 primary hypertension as experimental group and 20 healthy persons as control group. The function (proliferation and migration) of EPCs were analyzed by CCK8 and Transwell chambers. Results: Compared with the control group, the migration and proliferation function of EPCs in primary hypertension patients were significantly lower (p < 0.05). FMD in primary hypertension group was lower than that in healthy group (p < 0.05), and we found a strong unilabiate correlation between the migratory and proliferatory of circulating EPCs and FMD (r = 0.56, 0.41, p < 0.05, respectively). Conclusion: The function of EPCs decreased may be related with FMD injury.
文章引用：姬炳焕, 王祖棣, 黄芝团, 刘文辉. 原发性高血压患者内皮祖细胞功能变化及与FMD的相关性[J]. 临床医学进展, 2021, 11(12): 6143-6149. https://doi.org/10.12677/ACM.2021.1112912

参考文献

[1] Campbell, N.R.C. and Zhang, X. (2018) Hypertension in China. Circulation, 137, 2357-2359. [Google Scholar] [CrossRef] 
[2] Rapsomaniki, E., Timmis, A., George, J., et al. (2014) Blood Pressure and Incidence of Twelve Cardiovascular Diseases: Lifetime Risks, Healthy Life-Years Lost, and Age-Specific Associations in 1.25 Million People. The Lancet, 383, 1899-1911. [Google Scholar] [CrossRef] 
[3] Agita, A. and Alsagaff, M.T. (2017) Inflammation, Immunity, and Hypertension. Acta Medica Indonesiana, 49, 158-165.
[4] Asahara, T., Murohara, T., Sullivan, A., et al. (1997) Isolation of Putative Progenitor Endothelial Cells for Angiogenesis. Science, 275, 964-967. [Google Scholar] [CrossRef] [PubMed]
[5] Tesfamariam, B. (2016) Endothelial Repair and Regeneration Following Intimal Injury. Journal of Cardiovascular Translational Research, 9, 91-101. [Google Scholar] [CrossRef] [PubMed]
[6] Liu, X., Zhang, G., Zhang, X., et al. (2013) Lacidipine Improves Endothelial Repair Capacity of Endothelial Rogenitor Cells from Patients with Essential Hypertension. International Journal of Cardiology, 168, 3317-3326. [Google Scholar] [CrossRef] [PubMed]
[7] Sabatier, F., Camoin-Jau, L., Anfosso, F., et al. (2009) Circulating Endothelial Cells, Microparticles and Progenitors: Key Players towards the Definition of Vascular Competence. Journal of Cellular and Molecular Medicine, 13, 454-471. [Google Scholar] [CrossRef] [PubMed]
[8] 中国高血压防治指南发布, 继续沿用140/90 mmHg的诊断标准[J]. 中国循证心血管医学杂志, 2018, 10(9): 1098.
[9] Luo, S., Xia, W., Chen, C., et al. (2016) Endothelial Progenitor Cells and Hypertension: Current Concepts and Future Implications. Clinical Science (London, England: 1979), 130, 2029-2042. [Google Scholar] [CrossRef] 
[10] Chao, T.H., Chen, I.C., Lee, C.H., et al. (2016) Cilostazol Enhances Mobilization of Circulating Endothelial Progenitor Cells and Improves Endothelium-Dependent Function in Patients at High Risk of Cardiovascular Disease. Angiology, 67, 638-646. [Google Scholar] [CrossRef] [PubMed]
[11] Werner, N. (2005) Influence of Cardiovascular Risk Factors on Endothelial Progenitor Cells: Limitations for Therapy? Arteriosclerosis, Thrombosis, and Vascular Biology, 26, 257-266. [Google Scholar] [CrossRef] 
[12] Vasa, M., Fichtlscherer, S., Aicher, A., et al. (2001) Number and Migratory Activity of Circulating Endothelial Progenitor Cells Inversely Correlate with Risk Factors for Coronary Artery Disease. Circulation Research, 89, E1-E7. [Google Scholar] [CrossRef] [PubMed]
[13] Hill, J.M., Zalos, G., Halcox, J.P., et al. (2003) Circulating Endothelial Progenitor Cells, Vascular Function, and Cardiovascular Risk. The New England Journal of Medicine, 348, 593-600. [Google Scholar] [CrossRef] 
[14] Imanishi, T., Moriwaki, C., Hano, T., et al. (2005) Endothelial Progenitor Cell Senescence Is Accelerated in Both Experimental Hypertensive Rats and Patients with Essential Hypertension. Journal of Hypertension, 23, 1831-1837. [Google Scholar] [CrossRef] [PubMed]
[15] 鲁力, 周建中, 张铁须, 等. 原发性高血压对循环内皮祖细胞的影响[J]. 中国全科医学, 2008(9): 744-746.
[16] Muntner, P. (2018) Response to Letter to Editor “2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/ PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults”. Journal of the American Society of Hypertension, 12, 239. [Google Scholar] [CrossRef] [PubMed]
[17] Marumo, T., Uchimura, H., Hayashi, M., et al. (2006) Aldosterone Impairs Bone Marrow-Derived Progenitor Cell Formation. Hypertension, 48, 490-496. [Google Scholar] [CrossRef] 
[18] Zhang, X.Y., Su, C., Cao, Z., et al. (2014) CXCR7 Upregulation Is Required for Early Endothelial Progenitor Cell-Mediated Endothelial Repair in Patients with Hypertension. Hypertension, 63, 383-389. [Google Scholar] [CrossRef] 
[19] Suzuki, R., Fukuda, N., Katakawa, M., et al. (2014) Effects of an Angiotensin II Receptor Blocker on the Impaired Function of Endothelial Progenitor Cells in Patients with Essential Hypertension. American Journal of Hypertension, 27, 695-701. [Google Scholar] [CrossRef] [PubMed]
[20] Georgescu, A., Alexandru, N. andrei, E., et al. (2012) Circulating Microparticles and Endothelial Progenitor Cells in Atherosclerosis: Pharmacological Effects of Irbesartan. Journal of Thrombosis and Haemostasis, 10, 680-691. [Google Scholar] [CrossRef] [PubMed]
[21] Li, Y., Alatan, G., Ge, Z., et al. (2014) Effects of Benazepril on Functional Activity of Endothelial Progenitor Cells from Hypertension Patients. Clinical and Experimental Hypertension, 36, 545-549. [Google Scholar] [CrossRef] [PubMed]

为你推荐